EU ‘declares war’ on toxic chemicals: why big pharma and IT giants could flee Ireland for the US
The US could be the beneficiary of a potential blanket ban on the use of PFAS, better known as ‘forever chemicals’.
Hosted on MSN7d
Samsung Biologics secures record $1.41 billion deal with European client
Samsung Biologics has secured a record $1.41 billion contract with an unnamed European pharmaceutical company, the contract ...
EURACTIV3mon
Czech MEP urges EU to tackle pharma reliance, cut bureaucracy, curb monopolies
The EU’s increasing reliance on pharmaceutical production from non-EU countries, particularly India and China, has raised serious concerns, newly elected Czech MEP Ondřej Dostál (NI ...
openaccessgovernment7d
Why the pharmaceutical industry must go green
Health Care Without Harm aims to transform global healthcare to minimize its environmental impact and promote sustainability ...
Samsung Biologics secures largest-ever deal with European pharma giant
Samsung Group biotech unit is now Kospi's fourth-biggest company, outpacing world's largest CDMO, Lonza, in market cap ...